SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ArQule -- Ignore unavailable to you. Want to Upgrade?


To: Dr. John M. de Castro who wrote (288)8/18/1998 11:06:00 AM
From: Wally Mastroly  Read Replies (1) | Respond to of 399
 
ARQL downgrade -

biz.yahoo.com



To: Dr. John M. de Castro who wrote (288)8/18/1998 1:37:00 PM
From: StockDoc  Read Replies (1) | Respond to of 399
 
You wrote: " It is always possible that Roche's leads that they supplied to ARQL were poor to start with and that the target was just not viable for therapeutic effects. I hope that this latter scenario is the case."

Do you have any info on what specifically Roche was trying to achieve with ARQL? What's ARQL's next most promising product in your opinion?